4 Healthcare ETFs to Tap Into Eli Lilly's Post-Q3 Earnings Rally
Yesterday, 3:01 PM·
Medium Optimistic
Summary
Eli Lilly (LLY) rallied following its Q3 earnings report, which highlighted surging demand for its drugs. Zacks notes that four healthcare ETFs offer exposure to the stock’s post-earnings momentum. The article does not specify the ETFs or the size of the move.
Eli Lilly (LLY) rallied following its third-quarter earnings report, according to Zacks, which highlighted surging demand for the company’s drugs as the driver behind the move.
ETF Exposure to the Rally
In a Zacks article published November 5, 2026, the firm noted that four healthcare ETFs offer exposure to Eli Lilly’s post-earnings momentum.
The source material does not identify the specific ETFs or quantify the size of the stock’s move.
Key Points
- Eli Lilly reported third-quarter results, after which the stock rallied.
- Zacks attributes the rally to surging demand for the company’s drugs.
- Zacks identifies four healthcare ETFs as vehicles for exposure to the stock, without naming them in the summary provided.
The full Zacks article is available on zacks.com.